It looks like your are using Internet Explorer.

Unfortunately, Internet Explorer is an outdated browser and we do not currently support it fully. You are seeing a limited view of the meeting details below.

To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

Increase DTx Market Access and Adoption via Precision Patient Engagement

18th January @ 10:45AM EDT

*This meeting is not just focused on FDA approved/prescription-based DTx solutions, but also companions to medication therapy or a digital therapy itself.*

Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Building precise patient engagement strategies is key to drive adoption, hence better health outcomes, which will ultimately help increase market access. Personalization is key for DTx companies to deliver the right messages and therapies to the right patient and at the right time. In this meeting, we will focus on how we can use precision patient engagement to personalise the experience and increase market access and adoption. Join to discuss:

  • Engaging the person, not just the disease. Not all patients with the same disease are the same. How can DTx companies ensure they focus on the person rather than the disease?
  • The use of behavioural science for more precise patient engagement strategies. How can we use evidence-based behavioural and cognitive science to engage and activate patients? Why does this approach work and how can we successfully use it to customise the experience for each patient?
  • The impact of patient engagement on DTx market access. How can DTx companies leverage precision patient engagement to improve health outcomes and collect RWE that supports conversations with payers? What engagement data points should DTx suppliers use to show costs’ reductions, and get payers to cover as much as possible?
  • The importance of human interaction in patient engagement with digital therapies.
  • Personalization vs. Scaling. Is personalization possible when scaling?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Apply to Attend

Thank you! Your submission has been received.

An invite invite link has been sent to you if you do not already have a HealthXL account.
Oops! Something went wrong while submitting the form.

Increase DTx Market Access and Adoption via Precision Patient Engagement

Bob Gold
Founder and Chief Behavioral Technologist, GoMo Health
Kevin Darcy
Director, Link Strategy at Veeva Systems

Join this HealthXL Event today:

Participate in this Digital Health Sprint in order to:
- Deep dive into a topic over 2 focused sessions.
- Engage with a small group of 10 global thought-leaders throughout.
- This sprint is outcome-focused: HealthXL and participants create exclusive outputs.
- Grow your network with our break out sessions.


You actively participate in this discussion. Spaces are limited to 8 - 12 people, allowing you to focus on quality in-depth conversations.

Don't miss your opportunity to connect with senior leaders to shape the future of digital health. Because only if you are prepared now can you lead the future.

18th January @ 10:45AM EDT

*This meeting is not just focused on FDA approved/prescription-based DTx solutions, but also companions to medication therapy or a digital therapy itself.*

Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Building precise patient engagement strategies is key to drive adoption, hence better health outcomes, which will ultimately help increase market access. Personalization is key for DTx companies to deliver the right messages and therapies to the right patient and at the right time. In this meeting, we will focus on how we can use precision patient engagement to personalise the experience and increase market access and adoption. Join to discuss:

  • Engaging the person, not just the disease. Not all patients with the same disease are the same. How can DTx companies ensure they focus on the person rather than the disease?
  • The use of behavioural science for more precise patient engagement strategies. How can we use evidence-based behavioural and cognitive science to engage and activate patients? Why does this approach work and how can we successfully use it to customise the experience for each patient?
  • The impact of patient engagement on DTx market access. How can DTx companies leverage precision patient engagement to improve health outcomes and collect RWE that supports conversations with payers? What engagement data points should DTx suppliers use to show costs’ reductions, and get payers to cover as much as possible?
  • The importance of human interaction in patient engagement with digital therapies.
  • Personalization vs. Scaling. Is personalization possible when scaling?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Participants

Participants

Bob Gold

Founder and Chief Behavioral Technologist, GoMo Health

Kevin Darcy

Director, Link Strategy at Veeva Systems

Maya Desai

Director, Guidehouse

Patrick Leyseele

Founder and CEO, 3.life

Fulvio Michelis, PhD

Digital Strategy Director, Merck Group

Suresh Sarojani

CTO - MedTech, Capgemini Engineering

Narayan Iyengar

Director IT Business Partner - GDO Digital Innovation , Trial Management, BMS

Rick Bartels

Managing Partner , DTxCC

Simon Bock

Market Access Manager, Tiefenbacher Group

Ivan Jurisic

Business Analyst for Digital Therapeutics at Roche

Malin Johansson

Global Head of Digital Health Partnerships at Novo Nordisk

Marta Solé

Associate Director Digital Health, Accord Healthcare

Number of Participants


Up to 12
Date  
January 18, 2023
Community

Increase DTx Market Access and Adoption via Precision Patient Engagement

*This meeting is not just focused on FDA approved/prescription-based DTx solutions, but also companions to medication therapy or a digital therapy itself.*

Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Building precise patient engagement strategies is key to drive adoption, hence better health outcomes, which will ultimately help increase market access. Personalization is key for DTx companies to deliver the right messages and therapies to the right patient and at the right time. In this meeting, we will focus on how we can use precision patient engagement to personalise the experience and increase market access and adoption. Join to discuss:

  • Engaging the person, not just the disease. Not all patients with the same disease are the same. How can DTx companies ensure they focus on the person rather than the disease?
  • The use of behavioural science for more precise patient engagement strategies. How can we use evidence-based behavioural and cognitive science to engage and activate patients? Why does this approach work and how can we successfully use it to customise the experience for each patient?
  • The impact of patient engagement on DTx market access. How can DTx companies leverage precision patient engagement to improve health outcomes and collect RWE that supports conversations with payers? What engagement data points should DTx suppliers use to show costs’ reductions, and get payers to cover as much as possible?
  • The importance of human interaction in patient engagement with digital therapies.
  • Personalization vs. Scaling. Is personalization possible when scaling?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

Participate in the Meeting

HealthXL Meetings

HealthXL Digital Health Meetings connect you with senior leaders around the world to discuss, solve and support each other.

Your time is valuable. This is why each Digital Health Meeting is limited to 75 minutes - long enough for engaging discussions but short enough to fit into your busy weekly schedule.

Digital Health Meetings are fully interactive and promote conversation - be ready to talk!

Participant-Led

HealthXL Digital Health Meetings are not webinars. There is no audience, no recordings and no hiding behind a screen. Discuss, reflect and share learnings in a private but interactive group.

Developed for a Busy Schedule

No long speeches, no wait, no travel. Take a productive deep dive into different digital health topics in just 75 minutes - perfect for when you’re on a break.

A Community to connect and network

Join a community of gamechangers in digital health. With a HealthXL membership, you meet like-minded people with unique perspectives. And as a HealthXL member, you get access to regular Digital Health Meetings.

continueD learning

Stay informed on the HealthXL Communities Hub. Connect with your peers, receive notifications about the latest interactive Meetings, get curated digital health news and access industry reports, insights, shared resources and more.

Virtual Digital Health Meeting

Join from anywhere

No need for a high end laptop to display fancy 3D personas or interactive conference rooms: All you need is a working camera and an internet-ready device to join.

Apply to Attend now

The world of Digital Health in one Hub

Be ready for the future of Digital Health and join a community of passionate leaders, innovators and gamechangers. 

As a HealthXL member, you get access to a wealth of information, resources and connections. From daily curated news by our in-house expert team to industry reports each retailing at €2000 - you have the world of Digital Health right at your fingertips.

Our community is growing fast. Don’t miss out on your opportunity to lead the future.


Join the community here
Reports & Insights
Reports and insights shared by the DTx community
Curated
News
Daily DTx News Curated by our in-house experts
Lists & Dashboards
Interactive dashboards and downloadable organisation data

Your Digital Health Corner

All Posts
Commentary
January 26, 2023
Innovation in Pharma: Friend or Foe? (Part 1)
Innovation in Pharma: Friend or Foe? (Part 1)
Read More
Commentary
January 24, 2023
3 Big News Stories from January
3 Big News Stories from January
Read More
Commentary
January 17, 2023
Digital Health 2022: Highlights
Digital Health 2022: Highlights
Read More

Frequently Asked Questions

What is a HealthXL Digital Health Meeting?

HealthXL Digital Health Meetings are private group meetings limited to a maximum of 10 people across different demographic and stakeholder groups. They are not webinars, but participant-led group meetings to allow you to explore every facet of digital health with peers.

read more
view Less

How can I become a member of the Digital Health Community?

We invite you to create a free account on our Community Hub to have a look behind the curtains. We'd love to show you the platform in a personal call. Click here to schedule a free session with a member of our team.

read more
view Less

When can I access the Meeting recording?

Our Meetings are all about honest, open discussions. This is why we do not record our them. After each Meeting, if you were a participant, you will receive a link to the key takeaways; a short summary of the Meeting.

read more
view Less

I am participating in this meeting, but can't attend anymore. Can I cancel it?

It can always happen that you cannot attend meetings due to unforeseen reasons. Due to the small group size, even missing one person can be disruptive. We'd like to ask all participants to inform us with at least 48 hours notice or suggest a suitable replacement for themselves.

read more
view Less

Increase DTx Market Access and Adoption via Precision Patient Engagement

18th January @ 10:45AM EDT
Digital Therapeutics (DTx)

Increase DTx Market Access and Adoption via Precision Patient Engagement

18th January @ 10:45AM EDT
Digital Therapeutics (DTx)
Bob Gold
Founder and Chief Behavioral Technologist, GoMo Health
LinkedIn Profile
Kevin Darcy
Director, Link Strategy at Veeva Systems
LinkedIn Profile
Maya Desai
Director, Guidehouse
LinkedIn Profile
Patrick Leyseele
Founder and CEO, 3.life
LinkedIn Profile
Fulvio Michelis, PhD
Digital Strategy Director, Merck Group
LinkedIn Profile
Suresh Sarojani
CTO - MedTech, Capgemini Engineering
LinkedIn Profile
Narayan Iyengar
Director IT Business Partner - GDO Digital Innovation , Trial Management, BMS
LinkedIn Profile
Rick Bartels
Managing Partner , DTxCC
LinkedIn Profile
Simon Bock
Market Access Manager, Tiefenbacher Group
LinkedIn Profile
Ivan Jurisic
Business Analyst for Digital Therapeutics at Roche
LinkedIn Profile
Malin Johansson
Global Head of Digital Health Partnerships at Novo Nordisk
LinkedIn Profile
Marta Solé
Associate Director Digital Health, Accord Healthcare
LinkedIn Profile

Increase DTx Market Access and Adoption via Precision Patient Engagement

*This meeting is not just focused on FDA approved/prescription-based DTx solutions, but also companions to medication therapy or a digital therapy itself.*

Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Building precise patient engagement strategies is key to drive adoption, hence better health outcomes, which will ultimately help increase market access. Personalization is key for DTx companies to deliver the right messages and therapies to the right patient and at the right time. In this meeting, we will focus on how we can use precision patient engagement to personalise the experience and increase market access and adoption. Join to discuss:

  • Engaging the person, not just the disease. Not all patients with the same disease are the same. How can DTx companies ensure they focus on the person rather than the disease?
  • The use of behavioural science for more precise patient engagement strategies. How can we use evidence-based behavioural and cognitive science to engage and activate patients? Why does this approach work and how can we successfully use it to customise the experience for each patient?
  • The impact of patient engagement on DTx market access. How can DTx companies leverage precision patient engagement to improve health outcomes and collect RWE that supports conversations with payers? What engagement data points should DTx suppliers use to show costs’ reductions, and get payers to cover as much as possible?
  • The importance of human interaction in patient engagement with digital therapies.
  • Personalization vs. Scaling. Is personalization possible when scaling?

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

When:
18th January @ 10:45AM EDT
Apply to attend
Registration Closed

Join this group of peers and get a feel of what it's like to belong to a community of digital health gamechangers.

All meetings are limited to 10 people to allow for honest discussions, so apply fast or become a HealthXL member and get priority access to all meetings, latest industry reports and and much more.

Frequently asked questions: 

What are HealthXL Virtual Meetings?

HealthXL Virtual Meetings are private group meetings limited to 10 people across different demographic and stakeholder groups. For 75 minutes, you take a deep dive into your chosen topic and explore it from different angles. Virtual Meetings are not webinars: There is no audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And through our Community Hub, you stay up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

How can I connect with other digital health leaders?

HealthXL brings together gamechangers of digital health to support honest discussions in small, private groups. In our Community Hub, for which you can register for free, you can follow a wide range of communities across telehealth, digital therapeutics, patient engagement and more. As a full HealthXL member, you also get access to curated news, the latest insights and an expert network to connect with. Join exclusive virtual meetings to exchange strategies, viewpoints and learnings with members from like-minded yet diverse stakeholder groups.

What are the benefits of being a HealthXL community member?

As member of HealthXL, you join a community of digital health thought leaders, innovators and game changers around the world. With your membership, you get access to hundreds of insights, reports and resources. You can browse a database with over 90k healthcare organizations and view their active strategic partnerships, commercial relationships, latest funding rounds and research. Through our in-house curated digital health newsfeed, you stay informed on the most impactful news and you can regularly meet with members to share learnings, discuss the latest developments and connect with peers of different demographical stakeholder groups. Contact us today to find out about pricing options.

Through focus groups, we bring together 6-10 thought leaders and industry stakeholders in a series of virtual meetings to collaborate around a defined topic. Each meeting gives the group the opportunity to examine, analyze and collaborate with one another around a digital health topic as well as produce a shareable result.